Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Clinical Medicine
|
February 14, 2019
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in <i>Mycobacterium tuberculosis</i> Infection
Stephen Cerni, Dylan Shafer, Kimberly To, et al.
Journal of Clinical Medicine
|
August 13, 2020
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: <i>Mycobacterium avium</i> and <i>Mycobacterium abscessus</i>
Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Journal of Clinical Medicine
|
January 1, 2020
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially <i>Mycobacterium tuberculosis</i>
Steve Ferlita, Aram Yegiazaryan, Navid Noori, et al.
Proceedings. Biological Sciences
|
November 16, 2018
Neonatal mice exposed to a high-fat diet <i>in utero</i> influence the behaviour of their nursing dam
Marine Baptissart, Harold E Lamb, Kimberly To, et al.
BMC Bioinformatics
|
March 7, 2018
ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data models
Skylar W Marvel, Kimberly To, Fabian A Grimm, et al.
Biomolecular Concepts
|
June 1, 2021
Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of <i>Mycobacterium tuberculosis</i> infection
Ruoqiong Cao, Kimberly To, Nala Kachour, et al.
Biomolecular Concepts
|
May 9, 2021
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against <i>Mycobacterium bovis</i> BCG Strain in Individuals with Type 2 Diabetes
Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Frontiers in Immunology
|
September 25, 2020
Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] in Improving the Ability of First-Line Antibiotics to Inhibit <i>Mycobacterium tuberculosis</i> Inside <i>in vitro</i> Human Granulomas
Joshua Hernandez, David Ashley, Ruoqiong Cao, et al.
Journal of Clinical Medicine
|
July 3, 2020
Antimycobacterial Effects of Everolimus in a Human Granuloma Model
David Ashley, Joshua Hernandez, Ruoqiong Cao, et al.
Journal of Clinical Medicine
|
October 2, 2019
Elucidating the Efficacy of the Bacille Calmette-Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
Rachel Abrahem, Ruoqiong Cao, Brittanie Robinson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Clinical Medicine
|
February 14, 2019
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in <i>Mycobacterium tuberculosis</i> Infection
Stephen Cerni, Dylan Shafer, Kimberly To, et al.
Journal of Clinical Medicine
|
August 13, 2020
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: <i>Mycobacterium avium</i> and <i>Mycobacterium abscessus</i>
Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Journal of Clinical Medicine
|
January 1, 2020
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially <i>Mycobacterium tuberculosis</i>
Steve Ferlita, Aram Yegiazaryan, Navid Noori, et al.
Proceedings. Biological Sciences
|
November 16, 2018
Neonatal mice exposed to a high-fat diet <i>in utero</i> influence the behaviour of their nursing dam
Marine Baptissart, Harold E Lamb, Kimberly To, et al.
BMC Bioinformatics
|
March 7, 2018
ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data models
Skylar W Marvel, Kimberly To, Fabian A Grimm, et al.
Biomolecular Concepts
|
June 1, 2021
Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of <i>Mycobacterium tuberculosis</i> infection
Ruoqiong Cao, Kimberly To, Nala Kachour, et al.
Biomolecular Concepts
|
May 9, 2021
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against <i>Mycobacterium bovis</i> BCG Strain in Individuals with Type 2 Diabetes
Kimberly To, Ruoqiong Cao, Aram Yegiazaryan, et al.
Frontiers in Immunology
|
September 25, 2020
Cyclic Peptide [R<sub>4</sub>W<sub>4</sub>] in Improving the Ability of First-Line Antibiotics to Inhibit <i>Mycobacterium tuberculosis</i> Inside <i>in vitro</i> Human Granulomas
Joshua Hernandez, David Ashley, Ruoqiong Cao, et al.
Journal of Clinical Medicine
|
July 3, 2020
Antimycobacterial Effects of Everolimus in a Human Granuloma Model
David Ashley, Joshua Hernandez, Ruoqiong Cao, et al.
Journal of Clinical Medicine
|
October 2, 2019
Elucidating the Efficacy of the Bacille Calmette-Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
Rachel Abrahem, Ruoqiong Cao, Brittanie Robinson, et al.
Page
of 2